Nyxoah SA (EBR:NYXH)
Belgium
· Delayed Price · Currency is EUR 5.59
-0.08 (-1.41%)
At close: May 9, 2025, 5:30 PM CET
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €200.24 million as of May 15, 2025. Its market cap has decreased by -21.74% in one year.
Market Cap
200.24M
Enterprise Value
199.93M
Revenue
4.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.59
Market Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 200.24M, a decrease of -52.07%. That is a compound annual growth rate of -14.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2025 | 200.24M | -35.23% |
| Dec 31, 2024 | 309.15M | 153.09% |
| Dec 29, 2023 | 122.15M | -8.05% |
| Dec 30, 2022 | 132.85M | -72.29% |
| Dec 31, 2021 | 479.37M | 37.44% |
| Dec 31, 2020 | 348.77M | -16.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 29.84B |
| UCB SA | 29.77B |
| Financière de Tubize | 5.48B |
| Fagron NV | 1.55B |
| Ion Beam Applications | 340.95M |
| Onward Medical | 190.86M |
| Hyloris Pharmaceuticals | 162.40M |
| Sequana Medical NV | 54.82M |